Low-dose olanzapine for self-mutilation behavior in patients with borderline personality disorder [3]

Journal of Clinical Psychiatry

Volumn 62, Issue 4, 2001, Pages 296-297

  Hough, D W ^a  

^a MADIGAN ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT; OLANZAPINE; PSYCHOTROPIC AGENT;

ADULT; AUTOMUTILATION; BORDERLINE STATE; CASE REPORT; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; LETTER; PRIORITY JOURNAL; SIDE EFFECT;

EID: 0035013995     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v62n0413d     Document Type: Letter

References (10)

1. Clinical outcome of psychopharmacologic treatment of borderline and schizotypal personality disordered subjects
2. Pharmacotherapy of borderline personality disorder
3. Managing aggressive behavior in patients with obsessive-compulsive disorder and borderline personality disorder
4. Olanzapine safety and efficacy in patients with borderline personality disorder and comorbid dysthymia
5. Low-dose clozapine in acute and continuation treatment of severe borderline personality disorder
6. Remission of self-mutilation in a patient with borderline personality disorder during risperidone therapy
7. Risperidone in comorbid borderline personality disorder and dysthymia
8. Is psychopharmacological treatment effective for the symptoms of borderline personality disorder (BPD)?
9. Psychopharmacologic treatment of pathologic aggression
10. Fluoxetine trial in borderline personality disorder